HAE
Clinical trials for HAE explained in plain language.
Never miss a new study
Get alerted when new HAE trials appear
Sign up with your email to follow new studies for HAE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Silencing the gene: new trial aims to stop debilitating swelling attacks
Disease control Recruiting nowThis study is testing a new drug called ADX-324 to see if it can prevent the sudden, painful swelling attacks caused by hereditary angioedema (HAE). It will involve about 90 adults with HAE who will receive either the drug or a placebo. The main goal is to see if the drug reduces…
Matched conditions: HAE
Phase: PHASE3 • Sponsor: ADARx Pharmaceuticals, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New 'No-Surgery' option tested for painful hemorrhoids
Symptom relief Recruiting nowThis study is testing a procedure called hemorrhoidal artery embolization (HAE) to see if it can reduce symptoms like bleeding from internal hemorrhoids. The procedure works by blocking the small arteries that supply blood to the hemorrhoids. Researchers at UCLA will enroll 22 ad…
Matched conditions: HAE
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Apr 01, 2026 14:42 UTC